TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan gets FDA approval of blood pressure drug

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Tuesday, Nov. 13, 2012, 10:34 a.m.
 

Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.

Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.

Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. Couple taken into custody after 8-hour standoff in Hempfield
  2. Pirates notebook: Locke makes bid for final rotation spot, Tabata cut
  3. Police end standoff with New Kensington man
  4. Narduzzi set to begin more critical evaluations during Pitt football spring drills
  5. Hays eagle egg watch continues
  6. Connellsville church collects goods, money for the needy
  7. Tenebrae returns for Connellsville’s St. Rita Roman Catholic Church
  8. Calm dad known for work ethic, culinary skills
  9. North Buffalo man charged with distributing child porn
  10. Penguins slip past Sharks, 3-2, in shootout
  11. Freshman arrested in Burrell High School bomb threat